Streetbeat News

MRMD

MariMed Inc

Employees

326

Industry

Medicinal and Botanical Manufacturing

Open

0.16

Mkt cap

59M

Volume

18K

High

0.16

P/E Ratio

-5.17

52-wk high

0.39

Low

0.15

Div yield

N/A

52-wk low

0.14

The Viridian Credit Tracker model shows that credit quality in the cannabis industry has declined due to increased leverage from debt financing and rising interest rates. Trulieve (TCNNF) and TerrAscend (TRSSF) have improved their credit rankings, while MariMed (MRMD) and Vext (VEXTF) have seen declines. The model assesses credit quality based on liquidity, leverage, profitability, and size, and tracks capital raise and M&A activity in the cannabis sector. Companies that manage cash flow and credit quality effectively are expected to benefit from future market upswings.

Portfolio Pulse from Viridian Capital Advisors

December 11, 2023 | 7:02 pm

The Viridian Chart of the Week analyzes the potential impact of a DEA announcement on the top 15 Multi-State Operators (MSOs) in the cannabis industry. The MSOS ETF has seen a significant increase since the HHS rescheduling announcement but has dropped from its peak. Stocks like SHWZ and CBSTF have declined since the HHS announcement, suggesting less downside risk from negative DEA news. Conversely, stocks like AYR Wellness have seen substantial gains, indicating higher risk. The chart also considers the upside potential if the DEA ratifies Schedule 3, with stocks like TCNNF and Cannabist potentially seeing significant gains. Viridian suggests that gains could be even higher, referencing past price levels after the SAFE Act and Schumer/Booker proposal.

Portfolio Pulse from Viridian Capital Advisors

December 04, 2023 | 5:30 pm

On November 27, 2023, several cannabis stocks experienced significant price movements. EVIO led the gainers with a 9900.00% increase, while Cann Gr topped the losers with a 27.38% decline. Notable gainers included AusCann Group, Global Compliance, and Item 9 Labs, with increases of 212.50%, 66.67%, and 39.13% respectively. Among the losers, Rocky Mountain High, 1933 Industries, and iAnthus Capital Holdings saw declines of 21.21%, 15.00%, and 9.37%. Corbus Pharmaceuticals and Cara Therapeutics were notable NASDAQ-listed companies with gains and losses of 15.21% and 5.11% respectively.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 9:30 pm

On November 23, 2023, several marijuana stocks experienced significant price movements. Notable gainers included GrowLife with a 19900.00% increase, and 1933 Industries with a 25.00% rise. Corbus Pharmaceuticals, GrowGeneration, and Village Farms Intl also saw gains. Conversely, EVIO led the losers with a 50.00% drop, followed by Global Compliance and CordovaCann. Other notable decliners included Auxly Cannabis Group, Emeren Group, and Cara Therapeutics.

Portfolio Pulse from Benzinga Insights

November 23, 2023 | 9:30 pm

Cannabis stocks experienced significant movements on November 22, 2023. GrowLife (PHOT) saw an extraordinary surge, closing up 19900.00%, while EVIO led the losers with a 50.00% decline. Other notable gainers include 1933 Industries (TGIFF), Corbus Pharmaceuticals (CRBP), and GrowGeneration (GRWG). On the losing side, Global Compliance (FUAPF), CordovaCann (LVRLF), and Auxly Cannabis Group (CBWTF) saw substantial drops in their share prices.

Portfolio Pulse from Benzinga Insights

November 22, 2023 | 9:30 pm

MariMed Inc., a cannabis operator, lost $646,000 due to an email scam involving a forged email and unauthorized money transfer to a Chase Bank account. The scam occurred over several months and was reported in MariMed's recent quarterly report. The company is working with the FBI and local police, and an investigation by Chase Bank is ongoing. MariMed has also submitted a claim for corporate cybersecurity insurance and may reverse the expense if the funds are recovered.

Portfolio Pulse from Jelena Martinovic

November 22, 2023 | 6:59 pm

MariMed Inc. (OTCQX:MRMD) has closed a $58.7 million refinancing deal with a U.S. chartered bank, securing a 10-year mortgage loan with favorable terms. The loan is secured by the company's Maryland and Massachusetts assets, and the proceeds were used to pay off existing debts, freeing up other assets and brands. The deal is expected to save cash and support strategic growth, including mergers and acquisitions. MariMed's stock traded slightly lower following the announcement.

Portfolio Pulse from Jelena Martinovic

November 20, 2023 | 4:55 pm

On November 15, 2023, several cannabis-related stocks experienced significant price movements. Notable gainers included EVIO and MPX International, both soaring 9900.00% to close at $0.0001. Other gainers were AusCann Group Holdings, Heritage Cannabis Holding, GreenGro Technologies, MJ Holdings, Auxly Cannabis Group, C21 Investments, iAnthus Capital Hldgs, Zoned Props, Cresco Labs, GrowGeneration, Scotts Miracle Gro, Cansortium, Corbus Pharmaceuticals, 4Front Ventures, MedMen Enterprises, Tilray Brands, and Curaleaf Holdings. Conversely, notable losers included Item 9 Labs, Kaya Holdings, CordovaCann, 1933 Industries, Leafbuyer Techs, Eastside Distilling, CLS Holdings USA, 22nd Century Group, Cann Gr, Indiva, Cannabix Technologies, MariMed, Nextleaf Solutions, Zelira Therapeutics, and Cara Therapeutics.

Portfolio Pulse from Benzinga Insights

November 15, 2023 | 9:30 pm

Zuanic & Associates released reports on Verano Holdings, TILT Holdings, MariMed Inc., and Green Thumb Industries, analyzing their Q3 results and future outlook. Verano anticipates a 4Q decline due to various factors but shows positive cash flow trends. TILT exceeded 3Q expectations and is positioned for growth with new partnerships. MariMed's 4Q guidance is reduced due to expansion delays but has a positive outlook for CY24. Green Thumb's 3Q update lacks sales guidance for 4Q, but increased capital expenditures may boost 1H24 growth.

Portfolio Pulse from Nicolás Jose Rodriguez

November 14, 2023 | 8:58 pm

Cannabis stocks experienced significant movements on November 13, 2023. Notable gainers included AusCann Group Holdings, Auxly Cannabis Group, and Rocky Mountain High, with increases of 66.67%, 46.94%, and 26.32% respectively. Eastside Distilling, Cara Therapeutics, and SNDL also saw substantial gains. Conversely, EVIO led the losers with a 98% decline, followed by Global Hemp Group and 1933 Industries. Other notable decliners included Heritage Cannabis Holding, Elixinol Wellness, and Corbus Pharmaceuticals.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.